MedTrace Logo

Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18

NCT06113978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2023-11-02

No results posted yet for this study

Summary

In this study, the investigators aim to present fifteen years' experience of thoracoscopic sympathetic chain interruption for primary palmar hyperhidrosis in children and adolescents; evaluation of 3 different techniques (sympathectomy, sympathotomy, and clipping) regarding demographic data, surgical outcomes, complications, compensatory sweating, and patients' satisfaction.

Conditions

  • Hyperhidrosis
  • Children, Adolescents
  • Thoracoscopic Sympathetic Chain Interruption
  • Sympathetic Disorder

Interventions

PROCEDURE

Thoracoscopic sympathectomy

Medical file records of patients of both sexes, below 18 years of age, suffering from significant bilateral palmar hyperhidrosis, managed by thoracoscopic bilateral simultaneous sympathectomy.

PROCEDURE

Thoracoscopic sympathotomy

Medical file records of patients of both sexes, below 18 years of age, suffering from significant bilateral palmar hyperhidrosis, who underwent thoracoscopic bilateral simultaneous sympathotomy.

PROCEDURE

Thoracoscopic sympathetic chain clipping

Medical file records of patients of both sexes, below 18 years of age, suffering from significant bilateral palmar hyperhidrosis, treated by thoracoscopic bilateral simultaneous sympathetic chain clipping.

Sponsors & Collaborators

  • dr. Muhammad Abdelhafez Mahmoud, MD

    lead OTHER

Principal Investigators

  • Mohamed Ahmed A Alzayyat, MD · Deputy Dean, professor, Pediatric Surgery Department, Al-Azhar University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-03-15
Completion
2023-08-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06113978 on ClinicalTrials.gov